April 14, 2017 |
There are hundreds of drugs that treat cancer, and every patient reacts differently to each of them. SEngine Precision Medicine, a Seattle startup spun out of the Fred Hutchinson Cancer Research Center, aims to help with a new test called PARIS.
GeekWire